Midgard Science
I

Invenra

Madison, WI, United Statesinvenra.comFrom their website, Nov 2026

Work here? Claim this listing

About

Invenra develops and characterizes monoclonal, bispecific, and trispecific antibodies for drug discovery and development. It works with biotech and other research teams on discovery, expression, validation, and partnership programs, based in Madison, Wisconsin, United States.

Services

  • Monoclonal antibody discovery

    Produces fully human mAb leads with binding properties, developability data, and functional validation.

  • B-Body bispecific discovery

    Screens bispecific combinations in final therapeutic format and delivers lead candidates ready for cell line development.

  • B-Body bispecific expression

    Expresses and purifies customer-provided sequences as B-Body bispecific antibodies.

    Protein production

  • T-Body trispecific discovery

    Develops trispecific antibody candidates for three-target engagement in a custom partnership model.

  • Characterization and validation

    Provides functional immunology, biophysical developability, and binding data for molecules at any stage.

  • ADC program support

    Supports antibody-drug conjugation-compatible platform work and ADC-related development.

Turnaround
4 weeks to 4 months
What to send
  • Antigen
  • Purified recombinant antigens
  • Cell lines
  • VH/VL sequences for each binding arm
  • Target biology and program goals
Minimums and prices
  • $100K starting price for mAb Discovery
  • $200K starting price for B-Body Discovery
  • $3,750 per molecule for B-Body Expression

Capabilities

Assays and studies
  • Antibodies
  • Bispecifics
  • ADCs
  • Immunogenicity
  • Mammalian expression
  • Cross-reactivity testing
14 more
  • Affinity (KD) measurements
  • Cell-based functional screening
  • Binding kinetics
  • Epitope diversity
  • Validated cell binding analysis
  • In silico liability scanning
  • Mass spectrometry intact mass confirmation
  • Developability assays
  • Formulation optimization
  • Thermal stability
  • Self-association
  • Aggregation
  • Solubility
  • Immunogenicity risk
Scale and capacity
  • 30+ proprietary human phage libraries
  • 288+ bispecific combinations
  • 50 mL expression
  • 200 mL expression
  • 500 mL expression
Therapeutic areas
  • Cancer
  • Immuno-oncology

Instruments and platforms

  • Carterra LSA

Modalities and species

Modalities
  • Antibody
  • Bispecific
  • ADC
Species and models
  • Human phage libraries
  • CHO cells

Details

Type
CRDMO
Address
5510 Element Way Suite 400 Madison, WI 53719

Similar labs